1. Home
  2. PTCT vs BGC Comparison

PTCT vs BGC Comparison

Compare PTCT & BGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • BGC
  • Stock Information
  • Founded
  • PTCT 1998
  • BGC 1945
  • Country
  • PTCT United States
  • BGC United States
  • Employees
  • PTCT N/A
  • BGC N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • BGC Investment Bankers/Brokers/Service
  • Sector
  • PTCT Health Care
  • BGC Finance
  • Exchange
  • PTCT Nasdaq
  • BGC Nasdaq
  • Market Cap
  • PTCT 3.7B
  • BGC 4.3B
  • IPO Year
  • PTCT 2013
  • BGC 1999
  • Fundamental
  • Price
  • PTCT $50.34
  • BGC $9.43
  • Analyst Decision
  • PTCT Buy
  • BGC Strong Buy
  • Analyst Count
  • PTCT 14
  • BGC 2
  • Target Price
  • PTCT $63.57
  • BGC $14.50
  • AVG Volume (30 Days)
  • PTCT 939.9K
  • BGC 2.4M
  • Earning Date
  • PTCT 08-07-2025
  • BGC 07-29-2025
  • Dividend Yield
  • PTCT N/A
  • BGC 0.84%
  • EPS Growth
  • PTCT N/A
  • BGC 128.63
  • EPS
  • PTCT 7.51
  • BGC 0.27
  • Revenue
  • PTCT $1,772,758,000.00
  • BGC $2,252,851,000.00
  • Revenue This Year
  • PTCT $121.50
  • BGC $35.79
  • Revenue Next Year
  • PTCT N/A
  • BGC $9.83
  • P/E Ratio
  • PTCT $6.72
  • BGC $35.95
  • Revenue Growth
  • PTCT 91.12
  • BGC 13.24
  • 52 Week Low
  • PTCT $28.72
  • BGC $7.24
  • 52 Week High
  • PTCT $58.38
  • BGC $11.79
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 54.78
  • BGC 48.95
  • Support Level
  • PTCT $49.47
  • BGC $9.39
  • Resistance Level
  • PTCT $52.45
  • BGC $9.87
  • Average True Range (ATR)
  • PTCT 1.54
  • BGC 0.23
  • MACD
  • PTCT -0.09
  • BGC -0.03
  • Stochastic Oscillator
  • PTCT 49.17
  • BGC 38.89

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

Share on Social Networks: